NCM
ETON icon

Nantahala Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Nantahala Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.6M Hold
1,175,951
– – 1.41% 12
2026
Q1 		$29M Hold
1,175,951
– – 1.07% 22
2025
Q4 		$19.9M Hold
1,175,951
– – 0.66% 32
2025
Q3 		$25.6M Hold
1,175,951
– – 0.89% 24
2025
Q2 		$16.8M Hold
1,175,951
– – 0.66% 36
2025
Q1 		$15.3M Buy
1,175,951
+57,468
+5% +$868K 0.61% 27
2024
Q4 		$14.9M Buy
1,118,483
+119,750
+12% +$1.21M 0.64% 32
2024
Q3 		$5.99M Buy
998,733
+58,000
+6% +$245K 0.3% 63
2024
Q2 		$3.1M Buy
+940,733
New +$3.29M 0.18% 80

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Nantahala Capital Management's ETON Position: Q2 2026 in Review

Nantahala Capital Management held its Eton Pharmaceutcials (ETON) position steady in Q2 2026 at 1,175,951 shares worth $42.6M. The position accounts for 1.41% of the portfolio, ranked #12.

Nantahala Capital Management first reported a position in ETON in Q2 2024 and has held it in 9 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Nantahala Capital Management held 1,175,951 shares of Eton Pharmaceutcials worth $42.6M as of Q2 2026.
  • Nantahala Capital Management left its Eton Pharmaceutcials share count unchanged in Q2 2026.
  • Eton Pharmaceutcials made up 1.41% of Nantahala Capital Management's portfolio in Q2 2026, its #12 holding.
  • Nantahala Capital Management first reported a position in Eton Pharmaceutcials in Q2 2024 and has held it in 9 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.